Arrakis Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
February 27, 2017
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$38,000,000

Company Info
Founding Year
2015
Founders
Russell Petter, Ph.D., Alan Walts, Ph.D., Henri Termeer, Raj Parekh, Ph.D.
Company Description
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Market
Pharmaceuticals
Location
Waltham, MA, USA
Coinvestors
Advent Life Sciences, Canaan Partners, Celgene Corporation, Henri Termeer, Osage University Partners, Pfizer Strategic Investments Group

Links